PFAPA syndrome (Periodic Fever, Aphthous stomatitis, Pharyngitis, Adenitis).
This paper aims to remind paediatric clinicians to suspect and confirm 'PFAPA' syndrome (Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome). We report two cases of PFAPA syndrome: a 3-year-old healthy boy with atopic rhinitis and a boy aged 8 years 5 months who simultaneously had lymphocytic vasculitis syndrome treated with immunosuppressive drugs. Both met Marshall's criteria. The literature regarding PFAPA syndrome was complied using a Medline search for articles published between 1963 and 1998 and we then reviewed the reference lists of the articles. The Medline search revealed 28 cases with available clinical manifestations, management and prognosis. Our study describes two additional cases. We divided the cases into typical (28 cases) and atypical (two cases) PFAPA syndrome. In typical PFAPA, the age of onset was less than 5 years in most cases and the patients presented 4.9 +/- 1.4 days of fever (100%), pharyngitis (89.3%), cervical adenitis (72.1%), stomatitis (71.4%), malaise (64.3%), headache (60.7%), abdominal pain (53.6%) and nausea/vomiting (17.9%). Afebrile intervals were 3.2 +/- 2.4 months and increased with age. The time from initial onset to final episode was 3 years 7 months +/- 3 years 6 months. The total number of episodes was 8.3 +/- 2.5 (range 6-14). Effective treatment included steroids, tonsillectomy/adenoidectomy and cimetidine. The general outcome was good. In atypical PFAPF, the clinical manifestations were similar to those of typical PFAPA except that the age of onset was more than 5 years, and life-threatening intestinal perforation happened once in a patient with underlying Fanconi's anaemia. It was concluded that typical PFAPA syndrome is benign and can be diagnosed by detailed history-taking and from physical findings during repeated febrile episodes with tests to rule out other periodic fever syndromes. A review of the literatures since the first report in 1987 has shown that typical PFAPA syndrome is not associated with significant long-term sequelae and has a good response to steroids. One patient with atypical PFAPA, who received low-dose steroids for over 1 year, developed intestinal perforation after an increment of the 7-day steroid dose. If an underlying problem requires long-term immunosuppressive medication, it is wiser to choose cimetidine rather than increasing the steroid dosage to resolve atypical PFAPA.
Lee
W I
WI
Department of Pediatrics, Chang-Gung Children's Hospital and Chang Gung University, Taoyuan, Taiwan.
Yang
M H
MH
Lee
K F
KF
Chen
L C
LC
Lin
S J
SJ
Yeh
K W
KW
Huang
J L
JL
D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002927:Cimetidine / Q000627:therapeutic use; D005334:Fever / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008199:Lymphadenitis / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D008297:Male; D010612:Pharyngitis / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D013281:Stomatitis, Aphthous / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D013577:Syndrome; D014657:Vasculitis / Q000150:complications / Q000188:drug therapy
D007166:Immunosuppressive Agents; D002927:Cimetidine; D011239:Prednisolone; D001379:Azathioprine